(((R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazi
2 Inquiries
1985606-14-1
Pharmaceutical Grade
90%
Shanghai Port or Shenzhen Port
H&D
A temperature-controlled box with a capacity of up to 10g
2025-03-14
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Baloxavir marboxil
Other Name:CS-2794;S-033188;S-033188;XOFLUZA;Xofluza;aloxavir marboxil;PubChem ID: 124081896;Baloxavir marboxil;baloxavir marboxil S-033188
CAS No.:1985606-14-1
Molecular Formula:C27H23F2N3O7S
InChIKeys:HKVHAHZGMLTCDW-BWFGELNCSA-N
Molecular Weight:571.55
Exact Mass:571.55
EC Number:606-227-7
UNII:505CXM6OHG
NCI Thesaurus Code:C166177
Color/Form:White to yellow
ATC Code:J - Antiinfectives for systemic use
Categories:
Characteristics-
XLogP3:
2.24
Density:1.57±0.1 g/cm3(Predicted)
Boiling Point:712.8±70.0 °C(Predicted)
Water Solubility:Soluble in water
PKA:-1.46±0.40(Predicted)
Critical Temperature & Pressure:Sealed in dry,Store in freezer, under -20°C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Location:
Hengfeng Wanda (Hubei) Pharmaceutical Technology Co., LTD., Hongshan District, Wuhan City, Hubei Province, China
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
150
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2023
-
Certifications:
Brand certification certificate,QUALITY MANAGEMENT SYSTEM CERTIFICATE
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted
Egypt
Baloxavir Marboxil
3 KG Jun 5, 2026
United States
Baloxavir marboxil Pharmaceutical Raw Powder CAS
100 G Aug 21, 2025 Post an enquiry for this product